Original Research
Accepted on 10 Jul 2025
NAP1L5 in Acute Myeloid Leukemia: A Prognostic Biomarker and Potential Therapeutic Target
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1617564
Type at least 3 characters
1,870 articles
Original Research
Published on 10 Jul 2025
Patient and physician treatment preferences in relapsed/refractory follicular lymphoma: a discrete choice experiment in the United States, United Kingdom, France, Germany, Brazil, and Japan
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1589722
- 863 views
Original Research
Published on 09 Jul 2025
Efficacy and safety of rituximab-based chemoimmunotherapy in adult patients with Burkitt lymphoma in Korea
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1614506
- 310 views
Case Report
Published on 09 Jul 2025
Treatment of relapsed or refractory Hodgkin’s lymphoma with lenalidomide combined with PD-1 monoclonal antibody: a case report and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1632039
- 319 views
Original Research
Published on 08 Jul 2025
ZFAS1/STAT3 axis modulates imatinib resistance of chronic myeloid leukemia cells through glucose metabolism reprogramming
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1603060
- 381 views
Original Research
Published on 08 Jul 2025
Observations on seasonal occurrence in lymphomas with proven or presumed infectious etiology
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1586441
- 243 views
Case Report
Published on 08 Jul 2025
Isolated relapse of multiple myeloma in the central nervous system post autologous hematopoietic stem cell transplantation: a case report and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1628297
- 169 views
Original Research
Published on 08 Jul 2025
Long-term endocrine outcomes and quality of life in paediatric and young chronic myeloid leukaemia patients on tyrosine kinase inhibitor therapy: a prospective study from India
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1598104
- 332 views
Case Report
Accepted on 07 Jul 2025
A Familial Hematological Pedigree Reveals VHL Germline Mutation as a Principal Predisposition Factor with Additional Mutations Modulating Phenotypic Heterogeneity
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1630715
Original Research
Accepted on 04 Jul 2025
Disproportionality Analysis of Adverse Events Associated with Pacritinib: A Real-World Study Based on FDA Adverse Event Reporting System (FAERS) Database
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1618267
- 143 views
Original Research
Accepted on 04 Jul 2025
Frontline brentuximab vedotin-based therapy for newly diagnosed classical Hodgkin lymphoma: a meta-analysis of randomized controlled trials
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1636923
- 135 views
Review
Published on 04 Jul 2025
A deep dive into the surgical and pharmacological considerations of obesity in chronic myeloid leukemia: a narrative review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1616883
- 554 views
Perspective
Accepted on 30 Jun 2025
A Roadmap to Implementing Outpatient Administration of Bispecific Antibodies in Multiple Myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1630146
- 176 views
Original Research
Accepted on 27 Jun 2025
Identification and Visualization of Fusion Gene Subtypes in APL Using Spatial Attention Mechanisms in Vision Models
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1619296
- 130 views
Review
Accepted on 27 Jun 2025
Nestin in multiple myeloma: emerging insights into a potential therapeutic target
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1596928
Case Report
Accepted on 24 Jun 2025
A Novel t(15;17)(q24;q11.2) Translocation Involving NF1::SCAMP5 Fusion in a Patient with Myeloproliferative neoplasms: a case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1600963
- 106 views